TGA Approval

NPLATE romiplostim (rbe) 230 microgram powder for injection vial (283890)

ARTG ID

283890

ARTG Name

NPLATE romiplostim (rbe) 230 microgram powder for injection vial

Sponsor

Amgen Australia Pty Ltd

ARTG Date

October 23, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Amgen Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/2393e2ab04828cf2f1e4319b559ca0f4.pdf

Ingredient Name

Romiplostim

Empowering clinical research with data-driven insights and AI-powered tools.